Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Bronchitis Pipeline Report 2016 - Review of 9 Companies & Drug Profiles - Research and Markets

Research and Markets
Posted on: 28 Oct 16

Research and Markets has announced the addition of the "Bronchitis - Pipeline Review, H2 2016" report to their offering.

Bronchitis pipeline therapeutics constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 3, 1 and 4 respectively.

Bronchitis is an inflammation of the lining of bronchial tubes, which carry air to and from lungs. Symptoms include cough that produces mucus (sputum), which may be blood streaked, shortness of breath aggravated by exertion or mild activity, frequent respiratory infections that worsen symptom, wheezing, fatigue, ankle that affects both sides and headaches. Risk factors include smoking, low resistance and gastric reflux.

Bronchitis - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Bronchitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Bronchitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Bronchitis - Overview
  5. Pipeline Products for Bronchitis - Comparative Analysis
  6. Bronchitis - Therapeutics under Development by Companies
  7. Bronchitis - Therapeutics under Investigation by Universities/Institutes
  8. Bronchitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Bronchitis - Products under Development by Companies
  13. Bronchitis - Products under Investigation by Universities/Institutes
  14. Bronchitis - Companies Involved in Therapeutics Development
  • AstraZeneca Plc
  • DBV Technologies S.A.
  • F. Hoffmann-La Roche Ltd.
  • Hyundai Pharmaceutical Co., Ltd.
  • Invion Limited
  • Kyorin Pharmaceutical Co., Ltd.
  • Mucosis B.V.
  • Orbis Biosciences Inc
  • Recipharm AB

For more information about this report visit

View source version on

Business Wire

Last updated on: 28/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.